Avalon Pharmaceuticals to Present at Rodman and Renshaw 7th Annual Healthcare Conference
November 04 2005 - 4:14PM
PR Newswire (US)
GERMANTOWN, Md., Nov. 4 /PRNewswire-FirstCall/ -- Avalon
Pharmaceuticals, Inc. (Nasdaq and ArcaEx(R): AVRX) today announced
that Kenneth C. Carter, Ph.D., President & CEO is scheduled to
present at the Rodman and Renshaw 7th Annual Healthcare Conference
at the New York Palace Hotel in New York on Monday, November 7th at
4:15 pm EST. Dr. Carter will provide an update on the company in
the Holmes 2 conference room. About Avalon Pharmaceuticals, Inc.
Avalon Pharmaceuticals is a biopharmaceutical company focused on
the discovery and development of small molecule therapeutics.
Avalon seeks to discover and develop novel therapeutics through the
use of a comprehensive, innovative and proprietary suite of
technologies based upon large-scale gene expression analysis which
it calls AvalonRx(R). Avalon Pharmaceuticals was established in
1999 and is headquartered in Germantown, Maryland. Avalon
Pharmaceuticals, Inc. Noonan Russo Gary Lessing Wendy Lau Chief
Financial Officer Tel: (212) 845-4272 Tel: (301) 556-9900 Email:
Fax: (301) 556-9910 Email: DATASOURCE: Avalon Pharmaceuticals, Inc.
CONTACT: Gary Lessing, Chief Financial Officer of Avalon
Pharmaceuticals, Inc., +1-301-556-9900, Fax: +1-301-556-9910, ; or
Wendy Lau of Noonan Russo, +1-212-845-4272, , for Avalon
Copyright